Age-Related Changes in Liver Size and Hepatic Blood Flow: The Influence on Drug Metabolism in the Elderly

Clinical Pharmacokinetics

Volumn 15, Issue 5, 1988, Pages 287-294

  Woodhouse, K W ^a   Wynne, H A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

AGE; AGED; AUTOPSY; DRUG ELIMINATION; DRUG METABOLISM; HUMAN; LIVER BLOOD FLOW; NORMAL VALUE; PRIORITY JOURNAL; REVIEW;

AGED; AGING; HUMAN; LIVER; LIVER CIRCULATION; METABOLIC CLEARANCE RATE; ORGAN WEIGHT; PHARMACOKINETICS;

EID: 0023691250     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-198815050-00002     Document Type: Review

References (77)

1. Imipramine and desipramine disposition in the elderly
2. Theophylline pharmacokinetics in advanced age
3. Disposition of antipyrine and Phenytoin correlated with age and liver volume in man
4. Criteria for assessment of functional impairment in patients with cirrhosis of the liver
5. Observer variation in the clinical and radiological assessment of hepatosplenomegaly
6. Normal variability in weight of the adult human liver and spleen
7. The estimation of hepatic blood flow in man
8. Increased clearance of antipyrine and d-propanolol after phenobarbital treatment in the monkey
9. Uncertainties in geriatric data II: organ size
10. Liver volume determination by ultrasound: a feasibility study
11. The effect of ageing on the hepatic clearance of propranolol
12. Measurement of liver blood flow by means of a simple injection of bromosulphthalein without hepatic venous catheterisation
13. The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease
14. Computer-assisted liver mass estimation from gamma-camera images
15. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration
16. Effect of hypotension on liver blood flow and lidocaine disposition
17. Reduction of liver blood flow and propranolol metabolism by Cimetidine
18. Measurement of liver volume by ultrasound and computed tomography
19. Drug kinetics and hepatic blood flow
20. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man
21. The effect of adrenaline and noradrenaline on the liver blood flow
22. Observations on temperature, blood flow and heat production in the human liver in relation to environment and to glucose and insulin administration
23. Antipyrine kinetics in the elderly: prediction of age related changes in benzodiazepine oxidising capacity
24. Drug disposition in old age
25. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease
26. Predisposing factors in adverse reactions to drugs
27. Effect of age on hepatic clearance of propranolol in rats
28. Measurement of liver volume by emission computed tomography
29. Variation in the activity of liver microsomal drug metabolising enzymes in rats in relation to age
30. Hepatic metabolism of sulfobromophthalein in ageing rats
31. The effect of ageing on the hepatic metabolism of sulfobromophthalein in BN/Bi female and WAG/Rij male and female rats
32. An electromagnetic flowmeter: principle of the method and its application to blood flow measurements
33. Reduction of liver blood flow by Cimetidine
34. Estimation of hepatic blood flow with indocyanine green
35. Liver volume measurement by ultrasonography in normal subjects and alcoholic patients
36. Enterohepatic circulation of bromosulphthalein in intraduodenal, intraportal and intravenous dye administration in dogs
37. Profound reduction in morphine clearance and liver blood flow in shock
38. The effects of ageing on the hepatic microsomal mixed-function oxidase system of male and female monkeys
39. Palpatory estimation of liver size — within and between observer variation
40. A new method of transcutaneous measurement of portal blood flow by an ultrasonic ‘Duplex’ system composed of a pulsed doppler flowmeter and a linear-type real-time B-mode electroscanner
41. The pharmacokinetics of chlormethiazole following intravenous administration in the aged
42. Lignocaine kinetics in cardiac patients and aged subjects
43. Methods of assessment of the effect of drugs on liver blood flow in man
44. Liver blood flow and blood volume following chronic phenobarbitone administration
45. Liver size indices of drug metabolism in epileptics
46. Ultrasound determination of liver size and assessment of patients with malignant liver disease
47. Liver volume determination by ultrasonic scanning
48. The influence of liver disease on drug disposition
49. The determination of liver mass from radionuclide images
50. Reduced induction of drug metabolism in the elderly
51. Age changes in the human liver of different races
52. Direct measurement of hepatic blood flow in experimental animals
53. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance
54. Drug metabolism in the elderly: confounding of age, smoking and ethanol effects
55. Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow
56. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking
57. Technetium-99m NGA functional hepatic imaging preliminary clinical experience
58. Comparison of the hepatic mixed function oxidase system of young, adult and old non-human primates (Macaca nemestrina)
59. Antipyrine disposition and liver size in the elderly
60. Effect of age on liver function with particular reference to bromsulphelein excretion
61. In vivo hepatic volume determination using sonography and computed tomography
62. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking
63. Effects of age and cigarette smoking on propranolol disposition
64. The disappearance of colloidal radiogold from the circulation and its application to the estimation of liver blood flow in normal and cirrhotic subjects
65. Liver size and its post-mortem changes
66. The use of indocyanine green for the evaluation of hepatic function and blood flow in man
67. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing
68. Plasma aspirin esterase and cholinesterases in the elderly
69. Effect of ageing and cigarette smoking on antipyrine and indocyanine green elimination
70. Hepatic adverse drug reactions: the effect of age
71. The effect of age on pathways of drug metabolism in human liver
72. Phase I drug metabolism in ageing
73. The effect of age upon liver volume and apparent liver blood flow in healthy man
74. Effect of age on monooxygenase enzyme kinetics in rat liver microsomes
75. The effect of age upon the affinity of microsomal monooxygenase enzymes for substrate in human liver
76. Evaluation of liver volume and liver function following hepatic resection in man